Amino group modification inhibits ristocetin cofactor activity of human von Willebrand factor

Comparative Study

S A Santoro. Biochem Biophys Res Commun. 1982.

. 1982 Sep 30;108(2):479-85.

doi: 10.1016/0006-291x(82)90854-3.

No abstract available

Similar articles

Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
Santoro SA, Cowan JF. Santoro SA, et al. Biochim Biophys Acta. 1984 Feb 14;797(2):178-85. doi: 10.1016/0304-4165(84)90120-x. Biochim Biophys Acta. 1984. PMID: 6607747
von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
Hashimoto S, Suzuki K. Hashimoto S, et al. Nihon Ketsueki Gakkai Zasshi. 1979 Dec;42(6):851-63. Nihon Ketsueki Gakkai Zasshi. 1979. PMID: 317771 No abstract available.
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
Federici AB, Elder JH, De Marco L, Ruggeri ZM, Zimmerman TS. Federici AB, et al. J Clin Invest. 1984 Dec;74(6):2049-55. doi: 10.1172/JCI111628. J Clin Invest. 1984. PMID: 6239876 Free PMC article.
Platelets and von Willebrand disease.
Ruggeri ZM, Zimmerman TS. Ruggeri ZM, et al. Semin Hematol. 1985 Jul;22(3):203-18. Semin Hematol. 1985. PMID: 3929388 Review. No abstract available.
[Structural-functional features of factor VIII (FVIII) and its role in the cascade system of blood coagulation].
Gutsalo AE. Gutsalo AE. Ukr Biokhim Zh (1978). 1995 Jul-Aug;67(4):12-23. Ukr Biokhim Zh (1978). 1995. PMID: 8553466 Review. Russian.